About the Authors

Anke Zschüttig

Affiliation Institute of Medical Microbiology and Hygiene, TU Dresden, Dresden, Germany

Kurt Zimmermann

Affiliation SymbioPharm GmbH, Herborn-Hörbach, Germany

Jochen Blom

Affiliation CeBiTec, University of Bielefeld, Bielefeld, Germany

Alexander Goesmann

Affiliation CeBiTec, University of Bielefeld, Bielefeld, Germany

Christoph Pöhlmann

Affiliation Abteilung für Labormedizin, Robert Bosch Krankenhaus, Stuttgart, Germany

Florian Gunzer

florian.gunzer@tu-dresden.de

Affiliation Institute of Medical Microbiology and Hygiene, TU Dresden, Dresden, Germany

Competing Interests

The authors have read the journal’s policy and they have the following conflicts. KZ is an employee of SymbioPharm. FG, AZ and KZ have submitted a patent application disclosing the discovery of "Bacterially formed microcin S, a new antimicrobial peptide, effective against pathogenic microorganisms" (EP 11177451). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: FG AZ. Performed the experiments: AZ. Analyzed the data: AZ KZ CP FG. Contributed reagents/materials/analysis tools: KZ JB AG CP. Wrote the paper: AZ FG.